Incivek sales fell 74 percent from a year ago to $205.6 million and were also down from the prior quarter's sales of $222.8 million.
the # of new patients beginning treatment will continue to decline LOL
nothing in this call says to hang on at these levels. Losing market it share in one drug and gaining slowly in the other. If the market corrects this will fall right with it.